222 related articles for article (PubMed ID: 33536571)
1. Arrayed CRISPR reveals genetic regulators of tau aggregation, autophagy and mitochondria in Alzheimer's disease model.
Duan L; Hu M; Tamm JA; Grinberg YY; Shen F; Chai Y; Xi H; Gibilisco L; Ravikumar B; Gautam V; Karran E; Townsend M; Talanian RV
Sci Rep; 2021 Feb; 11(1):2879. PubMed ID: 33536571
[TBL] [Abstract][Full Text] [Related]
2. Selenomethionine Mitigates Cognitive Decline by Targeting Both Tau Hyperphosphorylation and Autophagic Clearance in an Alzheimer's Disease Mouse Model.
Zhang ZH; Wu QY; Zheng R; Chen C; Chen Y; Liu Q; Hoffmann PR; Ni JZ; Song GL
J Neurosci; 2017 Mar; 37(9):2449-2462. PubMed ID: 28137967
[TBL] [Abstract][Full Text] [Related]
3. mTor mediates tau localization and secretion: Implication for Alzheimer's disease.
Tang Z; Ioja E; Bereczki E; Hultenby K; Li C; Guan Z; Winblad B; Pei JJ
Biochim Biophys Acta; 2015 Jul; 1853(7):1646-57. PubMed ID: 25791428
[TBL] [Abstract][Full Text] [Related]
4. Bidirectional interplay of HSF1 degradation and UPR activation promotes tau hyperphosphorylation.
Kim E; Sakata K; Liao FF
PLoS Genet; 2017 Jul; 13(7):e1006849. PubMed ID: 28678786
[TBL] [Abstract][Full Text] [Related]
5. Gene Expression of Disease-related Genes in Alzheimer's Disease is Impaired by Tau Aggregation.
Siano G; Varisco M; Scarlatti A; Caiazza MC; Dunville K; Cremisi F; Costa M; Pancrazi L; Di Primio C; Cattaneo A
J Mol Biol; 2020 Dec; 432(24):166675. PubMed ID: 33058882
[TBL] [Abstract][Full Text] [Related]
6. Acyl-coenzyme A:cholesterol acyltransferase 1 blockage enhances autophagy in the neurons of triple transgenic Alzheimer's disease mouse and reduces human P301L-tau content at the presymptomatic stage.
Shibuya Y; Niu Z; Bryleva EY; Harris BT; Murphy SR; Kheirollah A; Bowen ZD; Chang CCY; Chang TY
Neurobiol Aging; 2015 Jul; 36(7):2248-2259. PubMed ID: 25930235
[TBL] [Abstract][Full Text] [Related]
7. Brain somatic mutations observed in Alzheimer's disease associated with aging and dysregulation of tau phosphorylation.
Park JS; Lee J; Jung ES; Kim MH; Kim IB; Son H; Kim S; Kim S; Park YM; Mook-Jung I; Yu SJ; Lee JH
Nat Commun; 2019 Jul; 10(1):3090. PubMed ID: 31300647
[TBL] [Abstract][Full Text] [Related]
8. Loss of presenilin function enhances tau phosphorylation and aggregation in mice.
Soto-Faguás CM; Sanchez-Molina P; Saura CA
Acta Neuropathol Commun; 2021 Sep; 9(1):162. PubMed ID: 34593029
[TBL] [Abstract][Full Text] [Related]
9. Amyloid Beta and Phosphorylated Tau-Induced Defective Autophagy and Mitophagy in Alzheimer's Disease.
Reddy PH; Oliver DM
Cells; 2019 May; 8(5):. PubMed ID: 31121890
[TBL] [Abstract][Full Text] [Related]
10. FRMD4A-cytohesin signaling modulates the cellular release of tau.
Yan X; Nykänen NP; Brunello CA; Haapasalo A; Hiltunen M; Uronen RL; Huttunen HJ
J Cell Sci; 2016 May; 129(10):2003-15. PubMed ID: 27044754
[TBL] [Abstract][Full Text] [Related]
11. Using Human iPSC-Derived Neurons to Model TAU Aggregation.
Verheyen A; Diels A; Dijkmans J; Oyelami T; Meneghello G; Mertens L; Versweyveld S; Borgers M; Buist A; Peeters P; Cik M
PLoS One; 2015; 10(12):e0146127. PubMed ID: 26720731
[TBL] [Abstract][Full Text] [Related]
12. Amyloidogenesis of Tau protein.
Nizynski B; Dzwolak W; Nieznanski K
Protein Sci; 2017 Nov; 26(11):2126-2150. PubMed ID: 28833749
[TBL] [Abstract][Full Text] [Related]
13. Autophagic dysfunction in Alzheimer's disease: Cellular and molecular mechanistic approaches to halt Alzheimer's pathogenesis.
Uddin MS; Mamun AA; Labu ZK; Hidalgo-Lanussa O; Barreto GE; Ashraf GM
J Cell Physiol; 2019 Jun; 234(6):8094-8112. PubMed ID: 30362531
[TBL] [Abstract][Full Text] [Related]
14. Brain region- and sex-specific alterations in mitochondrial function and NF-κB signaling in the TgCRND8 mouse model of Alzheimer's disease.
Djordjevic J; Thomson E; Chowdhury SR; Snow WM; Perez C; Wong TP; Fernyhough P; Albensi BC
Neuroscience; 2017 Oct; 361():81-92. PubMed ID: 28802916
[TBL] [Abstract][Full Text] [Related]
15. Myricetin slows liquid-liquid phase separation of Tau and activates ATG5-dependent autophagy to suppress Tau toxicity.
Dai B; Zhong T; Chen ZX; Chen W; Zhang N; Liu XL; Wang LQ; Chen J; Liang Y
J Biol Chem; 2021 Oct; 297(4):101222. PubMed ID: 34560101
[TBL] [Abstract][Full Text] [Related]
16. Impacts of DNA methylation on Tau protein related genes in the brains of patients with Alzheimer's disease.
Wei X; Du P; Zhao Z
Neurosci Lett; 2021 Oct; 763():136196. PubMed ID: 34437990
[TBL] [Abstract][Full Text] [Related]
17. Pathological Changes of Tau Related to Alzheimer's Disease.
Chu D; Liu F
ACS Chem Neurosci; 2019 Feb; 10(2):931-944. PubMed ID: 30346708
[TBL] [Abstract][Full Text] [Related]
18. Decrease of neuronal FKBP4/FKBP52 modulates perinuclear lysosomal positioning and MAPT/Tau behavior during MAPT/Tau-induced proteotoxic stress.
Chambraud B; Daguinot C; Guillemeau K; Genet M; Dounane O; Meduri G; Poüs C; Baulieu EE; Giustiniani J
Autophagy; 2021 Nov; 17(11):3491-3510. PubMed ID: 33459145
[TBL] [Abstract][Full Text] [Related]
19. Integrated biology approach reveals molecular and pathological interactions among Alzheimer's Aβ42, Tau, TREM2, and TYROBP in Drosophila models.
Sekiya M; Wang M; Fujisaki N; Sakakibara Y; Quan X; Ehrlich ME; De Jager PL; Bennett DA; Schadt EE; Gandy S; Ando K; Zhang B; Iijima KM
Genome Med; 2018 Mar; 10(1):26. PubMed ID: 29598827
[TBL] [Abstract][Full Text] [Related]
20. Norepinephrine metabolite DOPEGAL activates AEP and pathological Tau aggregation in locus coeruleus.
Kang SS; Liu X; Ahn EH; Xiang J; Manfredsson FP; Yang X; Luo HR; Liles LC; Weinshenker D; Ye K
J Clin Invest; 2020 Jan; 130(1):422-437. PubMed ID: 31793911
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
